More than 1 million children die every year from severe ognition domains with multiple specificities for sugar residues on microbial surfaces, resulting in opsonization via collectin malaria in areas of sub-Saharan Africa where Plasmodium falciparum is endemic [1] . In such areas, effective clinical immureceptors and/or complement activation [6] . MBL is thought to be most effective at an early age, before effective acquired nity develops only slowly after birth, and the burden of risk of developing severe disease is thus carried by young children immune responses have developed, acting as an ante-antibody, and MBL deficiency has thus been linked to chronic suscepti- [2] . These observations have prompted the search for mechanisms of protection, and innate resistance or susceptibility to bility to infection in children [7] . Low plasma concentrations of MBL result primarily from mutations in the coding region of severe malaria has thus recently been linked to genetic factors influencing immune responsiveness [3, 4] . the MBL gene, causing structural alterations in the collagenous region of the molecule, rendering the protein nonfunctional due Mannose-binding lectin (MBL) is a member of the collectin family of proteins, which are constituents of the innate immune its inability to form stable oligomers [6] . We determined, by comparing the plasma levels of this prosystem [5] . MBL mediates its effect through carbohydrate rectein and the MBL gene polymorphisms in individuals with either severe or mild malaria, whether MBL may influence the response to infection with P. falciparum in young African children. In the study area, the majority of malaria cases requir- be a prerequisite for a fatal outcome of malaria in this setting.
Hospital in Lambaréné, Gabon, which has been described in detail elsewhere [8] . Children (n Å 100) with severe malaria fulfilled the following inclusion criteria: P. falciparum malaria with ú1000 parasites/mL and older than 6 months, with severe malaria defined as severe anemia (hemoglobin õ50 g/L) and/or hyperparasitemia (ú250,000 parasites/mL corresponding to ú10% infected erythrocytes) and facultatively other signs of severe malaria [9] . As controls, sex-, age-, and provenance-matched children with mild malaria were admitted as soon as possible after each severe malaria patient. The following criteria for the mild malaria controls had to be fulfilled: P. falciparum malaria with a parasitemia of 1000-50,000/mL on admission, no schizontemia, malarial pigment-containing circulating leukocytes õ50/mL, hemoglobin ú80 g/L, platelets ú50/nL, leukocytes õ12/nL, lactate õ3 mmol/L, blood glucose ú50 mg/dL, no signs of severe malaria or other acute infections, no intake of antimalarial drugs within the preceding week, and no history of hospitalization (to exclude prior severe malarial attacks).
All 200 children were monitored in the acute phase of the disease, and after treatment they became subject to an ongoing, longitudinal, prospective study to compare reinfection rates with immune responses and other factors. Routine pediatric micromethods were used to measure hematologic and biochemical parameters and parasitemia [8] .
MBL measurements. Venous blood from study participants was collected into heparinized tubes at admission, after 1 month, Figure 1 . MBL plasma concentrations according to disease severity: Concentrations of MBL were measured in plasma samples taken during convalescence, and again after at least 6 months, when the at admission (0), after 1 month, and after at least 6 months, when children were healthy. Plasma was collected after centrifugation child was healthy. Box-whisker plots depict 10th, 25th, 50th, 75th, of blood and stored at 080ЊC. MBL was quantified in plasma and 90th percentiles. Circles represent outlying values, below and samples by EIA according to a published method [10] , using a above 10th and 90th percentiles, respectively. S Å severe malaria, M monoclonal anti-MBL antibody for capture and a biotinylated anti-Å mild malaria. MBL monoclonal antibody for detection (both from Statens Seruminstitut, Copenhagen), followed by extravidin-peroxidase (Sigma, Deisenhofen, Germany), and tetramethylbenzidine subtration of MBL. MBL concentrations are expressed as median { strate (Dunn Labortechnik, Asbach, Germany). The cutoff for this median absolute deviation in micrograms per liter of plasma. assay was 20 mg/L.
MBL gene polymorphisms. Polymorphisms in the MBL gene were detected by polymerase chain reaction (PCR) and DNA se- range of concentrations of MBL was narrower than in the acute pathogenic organisms. The diversity of its potential targets arises from the variety of specificities of its carbohydrate recogphase, and the median values in the 2 groups were similar. We detected two previously described mutations in exon 1 nition domains, through which it binds to microbial surfaces, opsonizing and/or activating complement via the lectin pathof the MBL gene, at codons 54 and 57. At least one mutation was present in 38% of the children, with an overall gene freway [6] . The gene frequencies for the two mutations we found in the Gabonese population studied here are in accordance with quency of 0.02 and 0.18 for codon 54 and 57 mutations, respectively. Mutations, in either the homozygous or heterozygous those reported for other African populations, as is the strong association we found between low MBL levels and presence state, were present at higher frequency in severe malaria patients than mild malaria controls (0.45 vs. 0.31, P Å .04). At of either mutation [11] . The fact that we found more MBL gene mutations in severe the individual mutation level, a significantly higher proportion of severe malaria patients than mild malaria controls carried malaria patients, associated with very low plasma MBL levels, raises the possibility that MBL has some role to play in protecthe mutation at codon 54 (0.08 vs. 0.01, P Å .04). Three individuals were homozygous for the codon 57 mutation. tion against malaria. Since MBL binds to surface glycoproteins on protozoal parasites [5] , a role could be envisaged for this Plasma levels of MBL in relation to the mutations are shown in table 1. Comparison of individuals with the wild-type MBL protein in inhibition of P. falciparum blood-stage multiplication through, for example, binding to carbohydrate residues on the gene showed that severe malaria patients had significantly higher (P õ .05) MBL levels in the acute phase of the infection. merozoite surface, thereby preventing invasion of erythrocytes. In this context, the glycosylphosphatidylinositol membrane anIn the convalescent phase, the median MBL level was still significantly higher (P õ .05) in severe than in mild malaria, chor, which is a constituent of the P. falciparum merozoite surface antigen-1, for example, represents a compelling potenbut after 6 months, there was no longer any difference between tial target for MBL binding through its multiple mannose resithe groups. The presence of a mutation in the MBL gene redues [12] . There is as yet no definitive proof that MBL binds sulted in uniformly low MBL levels regardless of an individuto such residues on merozoites. al's clinical presentation, so that, at any time point, a signifiClearly, however, in our study a high plasma level of MBL cantly higher proportion (ú85%) of those with an MBL was not on its own predictive of protection from severe malaria. concentration õ200 mg/L had an MBL gene mutation (P õ This much is evident from the comparison of individuals with .001). There was no significant difference between the groups the normal wild-type MBL gene, which showed that acutein the levels of MBL present at the different time points in phase MBL levels were significantly higher in severe malaria those with MBL gene mutations.
patients than in mild malaria controls. We would interpret these higher levels of MBL as reflecting a more intense acute-phase Discussion response induced in part, and indirectly, by the higher paraThe principal finding of this matched-pair case-control study sitemias in severe malaria patients compared with mild malaria is that structural polymorphisms of the MBL gene, which result controls. In general, severe malaria is a systemic life-threatenin low plasma concentrations of nonfunctional protein, are ing event during which the expression of all mediators of the more likely to be found in children with severe than mild innate immune response is highly up-regulated. Thus, if there malaria. One mutation, at codon 54, was significantly more is no impairment of the expression of a particular molecule, frequent in those with severe malaria.
the production of acute-phase proteins, inflammatory cytokines, As a component of the innate immune system, MBL has an oxygen radicals, and nitric oxide is acutely enhanced and higher plasma levels are consequently found in severe compared with important role to play as a first line of defense against multiple / 9d52$$oc31 09-01-98 19:36:50 jinfa UC: J Infect
